Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Revenue

Interpace Biosciences had revenue of $9.03M in the quarter ending March 31, 2026, a decrease of -21.56%. This brings the company's revenue in the last twelve months to $36.25M, down -24.90% year-over-year. In the year 2025, Interpace Biosciences had annual revenue of $38.73M, down -17.47%.

• Revenue (ttm): 36.25M
• Revenue Growth: -24.90%
• P/S Ratio: 1.35
• Revenue / Employee: 355.34K
• Employees: 102
• Market Cap: 48.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.73M	-8.20M	-17.47%
Dec 31, 2024	46.93M	6.89M	17.21%
Dec 31, 2023	40.04M	8.20M	25.75%
Dec 31, 2022	31.84M	-1.28M	-3.86%
Dec 31, 2021	33.12M	719.00K	2.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error